Efficacy and Safety of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: Real-World Data
Introduction: Glecaprevir/pibrentasvir (G/P) is a pan-genotypic direct-acting antiviral therapy approved for use in adults with chronic hepatitis C virus (HCV) infection. This study aimed to assess the real-world efficacy and safety profile of G/P in individuals with chronic HCV. Materials and Meth...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2025-07-01
|
| Series: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
| Subjects: | |
| Online Access: | https://mjima.org/articles/efficacy-and-safety-of-glecaprevirpibrentasvir-in-chronic-hepatitis-c-patients-real-world-data/doi/mjima.galenos.2025.25430.12 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!